At 1 year (%) | At 2 years (%) | At 3 years (%) | P | |
---|---|---|---|---|
P65 expression | ||||
Negative | 88 | 76 | 72 | |
Positive | 43 | n.a. | n.a. | <0.001 |
Age | ||||
≤ 60 years | 83 | 70 | 67 | |
≥ 61 years | 90 | 79 | 75 | 0.23 |
Gender | ||||
Female | 91 | 78 | 78 | |
Male | 84 | 71 | 67 | 0.31 |
Karnofsky performance score | ||||
≤ 70 | 83 | 69 | 64 | |
≥ 80 | 88 | 77 | 74 | 0.19 |
Hemoglobin level pre-RT | ||||
< 12 g/dl | 79 | 60 | 60 | |
≥ 12 g/dl | 89 | 78 | 73 | 0.037 |
Tumor Site | ||||
Oropharynx | 91 | 83 | 79 | |
Oral Cavity/Floor of mouth | 74 | 46 | 46 | |
Hypopharynx | 82 | 71 | 71 | |
Larynx | 87 | 77 | 69 | 0.050 |
Histologic grade | ||||
G1-2 | 91 | 78 | 74 | |
G3 | 82 | 70 | 67 | 0.24 |
HPV status | ||||
Negative | 84 | 69 | 65 | |
Positive | 94 | 94 | 94 | 0.041 |
T-classification | ||||
T1-T2 | 92 | 83 | 77 | |
T3-T4 | 80 | 64 | 64 | 0.007 |
N-classification | ||||
N0-N2a | 90 | 82 | 82 | |
N2b-N3 | 83 | 68 | 63 | 0.040 |
AJCC stage | ||||
Stage III | 91 | 82 | 82 | |
Stage IV | 83 | 68 | 63 | 0.042 |
Extent of resection | ||||
Complete | 88 | 75 | 71 | |
Incomplete | 78 | 67 | 67 | 0.46 |
Chemotherapy | ||||
No | 87 | 77 | 70 | |
Yes | 85 | 69 | 69 | 0.99 |